Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Creative Medical Technology Holdings (CELZ) Return on Sales (2017 - 2025)

Creative Medical Technology Holdings (CELZ) has disclosed Return on Sales for 11 consecutive years, with 993.57% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Sales fell 51012.0% to 993.57% in Q3 2025 year-over-year; TTM through Sep 2025 was 993.57%, a 51012.0% decrease, with the full-year FY2024 number at 499.41%, up 8799.0% from a year prior.
  • Return on Sales was 993.57% for Q3 2025 at Creative Medical Technology Holdings, down from 960.93% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 17.86% in Q3 2022 to a low of 993.57% in Q3 2025.
  • A 5-year average of 347.51% and a median of 242.33% in 2023 define the central range for Return on Sales.
  • Peak YoY movement for Return on Sales: surged 214966bps in 2021, then plummeted -76622bps in 2025.
  • Creative Medical Technology Holdings' Return on Sales stood at 57.2% in 2021, then plummeted by -484bps to 334.18% in 2022, then tumbled by -67bps to 559.52% in 2023, then decreased by -10bps to 618.02% in 2024, then crashed by -61bps to 993.57% in 2025.
  • Per Business Quant, the three most recent readings for CELZ's Return on Sales are 993.57% (Q3 2025), 960.93% (Q2 2025), and 546.03% (Q1 2025).